Research Grants

Grant Name
Research Grants
Funder
International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Country or Region
United States
Research Field
Blood Diseases
Bone Marrow
Cancer Biology
Cancer or Carcinogenesis
Epigenetics
Genomics
Immunology
Immunotherapy
Oncology
Tumor Immunology
Deadline
February 13, 2022 (Expired)
Grant Size
Upper $400,000USD Under the Roadmap Initiative, the IWMF will award Roadmap grants for 2-4 new research proposals each year, depending on funding availability. Each project shall be 2 years in length, at a cost of up to $200,000 per year per project.
Contact Info
Dr. Tom Hoffmann, IWMF Research Committee thoffmann@iwmf.com
Jennifer Silva, IWMF Operations Manager jsilva@iwmf.com
Eligibility
Applicants must hold an M.D., Ph.D., or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories. Applications may involve multiple such institutions, and the applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on applicant age, race, gender, or creed. Applications from non-academic facilities, postdoctoral positions, and the National Institutes of Health are not eligible.
Description
The International Waldenstrom's Macroglobulinemia Foundation (IWMF) and the Leukemia & Lymphoma Society (LLS) are proud to announce the fourth IWMF-LLS STRATEGIC RESEARCH ROADMAP INITIATIVE - a Request for Proposals (RFP) to help further knowledge in four key domains of Waldenstrom's macroglobulinemia (WM) research:
- Genomics and Epigenomics
- Signaling
- Immunology/Immunotherapy
- Bone Marrow/Tumor MicroenvironmentThe IWMF supports research to understand the biology of WM, with the goals of improving quality of life for WM patients, discovering new treatments, and ultimately, finding a cure. IWMF funding for research has helped to provide insight into understanding the basic biology and genetics of WM. This research in turn has played a significant role in the development of treatments and treatment guidelines in current use, as well as potential new drugs still in the pipeline. Eligibility Applicants must hold an M.D., Ph.D., or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories. Applications may involve multiple such institutions, and the applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on applicant age, race, gender, or creed. Applications from non-academic facilities, postdoctoral positions, and the National Institutes of Health are not eligible.

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

February 13, 2022

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

Related opportunities

International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Aged Care Services - Specialist Dementia Care Program
Aged Care 30-Jun-2024 $5,500,000.00
Northern Territory Pathways to Community Control
Indigenous Health 30-Jun-2024 $8,750,000.00
Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
Strategic Prevention Framework – Partnerships for Success for States
Health Jun 05, 2025 12:00:00 AM EDT $1,250,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers
Medicine September 30, 2025 Up to 75,000,000 USD
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
Health and Medical Research 31-Mar-2026 $400,000,000.00